News

As part of BiotechTV’s tour of the Basel Area biotech ecosystem, our CEO Andrea Chicca discussed Synendos’ approach to restoring balance in the brain’s endocannabinoid system and our clinical progress in anxiety disorders. Watch the full interview:

Dr. Andrea Chicca, CEO, shares the highly promising results from Synendos Phase 1 Trials

Synendos was proud to attend, as a finalist, the highly prestigious Swiss Economic Forum Awards

Lichtsteiner Foundation Testimonial Film about Synendos